Gupta..

New Post Public Reply Private Reply Replies (0) Message Board
newjack
Gupta..

http://www.cnn.com/2014/03/05/health/gupta-me...marijuana/

Editor's note: Don't miss "Weed 2: Cannabis Madness: Dr. Sanjay Gupta Reports," at 10 p.m. ET on Tuesday. Also, Dr. Gupta will be answering your questions on Reddit at noon ET Friday.

(CNN) -- It's been eight months since I last wrote about medical marijuana, apologizing for having not dug deeply into the beneficial effects of this plant and for writing articles dismissing its potential . I apologized for my own role in previously misleading people, and I feel very badly that people have suffered for too long, unable to obtain the legitimate medicine that may have helped them.

I have been reminded that a true and productive scientific journey involves a willingness to let go of established notions and get at the truth, even if it is uncomfortable and even it means having to say "sorry."

It is not easy to apologize and take your lumps, but this was never about me.

This scientific journey is about a growing number of patients who want the cannabis plant as a genuine medicine, not to get high.

Dr. Sanjay Gupta is a practicing neurosurgeon and CNN\'s chief medical correspondent.
Dr. Sanjay Gupta is a practicing neurosurgeon and CNN's chief medical correspondent.

It is about emerging science that not only shows and proves what marijuana can do for the body but provides better insights into the mechanisms of marijuana in the brain, helping us better understand a plant whose benefits have been documented for thousands of years. This journey is also about a Draconian system where politics override science and patients are caught in the middle.

Since our documentary "Weed" aired in August, I have continued to travel the world, investigating and asking tough questions about marijuana.

I have met with hundreds of patients, dozens of scientists and the curious majority who simply want a deeper understanding of this ancient plant. I have sat in labs and personally analyzed the molecules in marijuana that have such potential but are also a source of intense controversy. I have seen those molecules turned into medicine that has quelled epilepsy in a child and pain in a grown adult. I've seen it help a woman at the peak of her life to overcome the ravages of multiple sclerosis.

Georgia House approves medical marijuana
Fla. to vote on medical marijuana
Can medical marijuana help seizures?

I am more convinced than ever that it is irresponsible to not provide the best care we can, care that often may involve marijuana.

I am not backing down on medical marijuana; I am doubling down.

I should add that, although I've taken some heat for my reporting on marijuana, it hasn't been as lonely a position as I expected. Legislators from several states have reached out to me, eager to inform their own positions and asking to show the documentary to their fellow lawmakers.

I've avoided any lobbying, but of course it is gratifying to know that people with influence are paying attention to the film. One place where lawmakers saw a long clip was Georgia, where the state House just passed a medical marijuana bill by a vote of 171-4. Before the legislative session started, most people didn't think this bill had a chance.

More remarkable, many doctors and scientists, worried about being ostracized for even discussing the potential of marijuana, called me confidentially to share their own stories of the drug and the benefit it has provided to their patients. I will honor my promise not to name them, but I hope this next documentary will enable a more open discussion and advance science in the process.

Marijuana is classified as a Schedule I substance , defined as "the most dangerous" drugs "with no currently accepted medical use."

Neither of those statements has ever been factual. Even many of the most ardent critics of medical marijuana don't agree with the Schedule I classification, knowing how it's impeded the ability to conduct needed research on the plant.

Even the head of the National Institute on Drug Abuse , Dr. Nora Volkow, seems to have softened her stance; she told me she believes we need to loosen restrictions for researchers.

Along the way, the public has become intensely engaged. Our collective society has paid closer attention to this issue than ever before, and with that increased education, support for medical marijuana has only grown , including in some unexpected places.

Pete Carroll, the coach of the Super Bowl-winning Seattle Seahawks, said the National Football League should explore medical marijuana if it helps players. NFL Commissioner Roger Goodell hasn't dismissed the idea, saying that if marijuana is reconsidered by the medical establishment, the league would treat it the same as any other medicine. Goodell also says the NFL is following the science that suggests marijuana may help recovery from concussions.

Recently, I had the chance to tell him that the United States already holds a patent on medical marijuana for that very purpose. Patent No. 6630507 : Cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke or trauma.

However, this particular issue still bothers me: How can the government deny the benefits of medical marijuana even as it holds a patent for those very same benefits? Members of the Food and Drug Administration declined my repeated requests for an interview.

This past year, President Barack Obama told the New Yorker magazine, "I don't think (marijuana) is more dangerous than alcohol." And yet, as alcohol remains available to any adult, the president has not moved to remove marijuana from the list of the most tightly controlled substances in the country.

Since I started my reporting on this topic, I have mostly resisted temptation to inject a subjective moral equivalency into this discussion, such as pitting alcohol against marijuana or reminding you that cocaine and methamphetamine are actually more available than marijuana to patients, physicians and medical researchers: They are Schedule II drugs, with recognized medical uses. Or telling you that on average, a person dies every 19 minutes in this country from a legal prescription drug overdose, while it is virtually unheard-of to die from a marijuana overdose.

But, with a discussion like this, consistency does matter. Terms matter, too.

We are talking about a medicine, known scientifically as cannabis. In order for people to start thinking of this substance as a medicine, perhaps we should start calling it by its medical name, something that was suggested to me by medical marijuana advocates pretty much everywhere I went this year.

I've tried to pull together these latest developments in our new documentary, " Cannabis Madness ." Although the 1936 film "Reefer Madness" was propaganda made to advance an agenda with dramatic falsehoods and hyperbole, I hope you will find "Cannabis Madness" an accurate reflection of what is happening today, injected with the best current science.

You will meet families all across the country -- a stay-at-home mom from Ohio, a nurse practitioner from Florida, an insurance salesman from Alabama -- more than 100 families who have all left jobs, homes, friends and family behind and moved to Colorado to get the medicine that relieves their suffering.

As things stand now, many of these good people don't ever get to return home. Why? Because transporting their medicine, even if it is a non-psychoactive cannabis oil, could get them arrested for drug trafficking. And so they are stuck, cannabis refugees.

You will meet them, and if you're like me, you'll be heartbroken to hear their stories, but you'll also have a lump in your throat when you see the raw, true love these parents have for their sick children.

History books may one day draw a parallel between this chapter of medical marijuana and the story of David and Goliath. Playing the role of David's slingshot, which ultimately brought Goliath to his knees, would be a 2-year-old girl named Vivian Wilson. She inspired her father to challenge the system in a spectacular way that caused a nation to stop for a moment and take note.

For months, we have filmed and followed the Wilson family with all of their trials and tribulations, and you will meet the whole family in the upcoming documentary.

I am a father myself, first and foremost. I don't want my children taking or being offered a psychoactive substance. As a neurosurgeon, I know that the developing brain is more susceptible to the most harmful effects of cannabis and that brain development continues well into our mid-20s.

I also worry that generations from now, my great-grandkids will find Internet headlines referring to me as the "pot doc." I do hope they will also read the rest of the story and understand the lives of the countless people who have suffered needlessly when a plant could have helped. I hope they know that I have dedicated my time to researching the medical literature, speaking to the scientists in person and piecing together a fact-based presentation meant to educate, not frighten.

I hope future generations won't consider me naive. Yes, I know there is a concern that many people out there will feign ailments just to get marijuana. But withholding legitimate treatment for the needy is a very unjust way of addressing that concern.

As a physician and reporter, I feel a deeper obligation to present the real stories, soundly supported with the science from all over the world.

When I first apologized for my previous marijuana reporting, I was thinking about the impact that reporting may have had on Charlotte Figi. She is a sweet little girl whose brain was locked in nearly nonstop seizure activity . Without success, she tried seven different medications, stringent diets and high-dose supplements. Modern medicine had nothing more to offer, which is why her parents turned to an ancient plant. As you know, it worked.

And, as you will see, she is one of so many patients out there, suffering from different ailments, who believe cannabis rescued them when nothing else did.

For conditions like Charlotte's, the American Epilepsy Society says that there are a million people for whom existing therapies do not control their seizures. The society recently said anecdotes about medical marijuana "give reason for hope" and said it supports "well-controlled studies that will lead to a better understanding of the disease and the development of safe and effective treatments."

You should know that Charlotte continues to do well. When I saw her around the holidays, she ran over and gave me a hug. She looked me in the eyes, took me by the hand and led me all around to meet her friends. She is a delightful, happy and now healthy little girl.

I know the discussion around this topic will no doubt get heated. I have felt that heat. But I feel a greater responsibility than ever to make sure those heated discussions are also well-informed by science.

And, with that: I hope you get a chance to watch on March 11 at 10 p.m. Eastern.

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Beauty Icon Awards: Honoring Black Beauty Excellence

Updated Category News Views 6

When it comes to honoring legacy and future within the Black beauty industry, the 2026 Beauty Icon Awards seem ready to steal the spotlight. Set to take place on October 10th at Atlanta's Riverside EpiCenter, this gathering is more than just a fancy shindig – it's a tribute to Black beauty's massive influence on culture and commerce. Celebrating Pioneers and Innovators...

Continue Reading
TerraMaster 725 NAS Unveils AI-Era Storage Solutions

Updated Category News Views 3

Tech Giants and Pioneers Rejoice Strap in, because TerraMaster just waved the green flag on their brand-new 725 Series Xeon Rackmount NAS, and it's high time the data storage world got a shake-up. Picture this: we're in the throes of an AI boom, and companies have data needs that gobble up yesterday's solutions with the hunger of a black hole. Well, enter TerraMaster's...

Continue Reading
Holland America Overhauls Half Moon Cay Offerings

Updated Category News Views 4

A Fresh Chapter for Half Moon Cay Mark it down, folks—Holland America Line is shaking things up over at RelaxAway, Half Moon Cay. The cruise line, known for its deep roots in premium cruising, is pouring resources into its private island playground to celebrate its 30th anniversary in 2027. And the timing couldn't be more calculated, what with peak cruise season around...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 3

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading
Charter Next Generation Taps Herndon as Financial Chief

Updated Category News Views 6

Bringing New Leadership to Charter Next Generation It's an intriguing time to be watching Charter Next Generation (CNG) as they just added a heavyweight to their executive team. Todd Herndon, a veteran with more than three decades of financial savvy, steps in as their new Chief Financial Officer. This is like a football team drafting a star quarterback right before the...

Continue Reading
Saudi Arabia Unveils CEER's Flagship Electric Vehicles

Updated Category News Views 4

CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...

Continue Reading
iFranchise Holds Top Spot in Consulting for 8 Years

Updated Category News Views 4

iFranchise's Unyielding Dominance in Franchise Consulting Five seconds in the franchise game, and you'd know that staying on top is a grind. But when you're iFranchise Group, it seems like the eighth time is the charm—if there ever was a need for luck. These folks have secured the number one spot in Entrepreneur magazine's Top Franchise Suppliers ranking yet again....

Continue Reading
ABnet Touts Anthropic's AI in Corporate Evolution

Updated Category News Views 7

Changing the AI Game in Enterprise At the heart of Tel Aviv-Yafo, ABnet Communication Ltd. is spitting fire, and this ain't your average tech chatter. They're drilling right down to the marrow, stressing just how much Anthropic—kingpin of advanced AI for enterprises—is shaking up the corporate shell game. Today’s conversation leans heavily into autonomous AI, and...

Continue Reading
Beemo, Choreo Forge AI Partnership for Wealth Management

Updated Category News Views 7

AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...

Continue Reading
ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Updated Category News Views 2

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

Continue Reading

Top 5 Most Recently Viewed Articles

Photocure ASA Reports Strong Q4 Results with Growth Prospects

Updated Category News Views 85

Photocure ASA Delivers Impressive Fourth Quarter Results Photocure ASA (OSE: PHO) recently announced its remarkable performance in the fourth quarter of 2024, showcasing significant growth in revenue from its flagship products, Hexvix and Cysview. Revenues reached NOK 128.6 million, representing a 13% increase from the same period in 2023, which recorded NOK 114.2...

Continue Reading
Insights on Financial Predictions for Tryg A/S Ahead of Q3

Updated Category News Views 76

Understanding Tryg A/S Consensus Estimates As the financial community eagerly awaits the Q3 report, Tryg A/S has gathered insightful consensus estimates from a diverse group of 16 expert analysts. This collective analysis aims to provide a clearer picture on how the company is projected to perform in the upcoming quarter. Analyst Contributions and Their Importance The...

Continue Reading
ADAMA Ltd. Launches Advanced Chloralkali Plant for Sustainability

Updated Category News Views 64

ADAMA Ltd. Unveils Innovative Chloralkali Production Facility ADAMA Ltd., a leader in the crop protection sector, recently celebrated the inauguration of its highly advanced chloralkali production facility. This new establishment signifies a considerable leap forward in sustainable agricultural solutions and production efficiency. State-of-the-Art Facility Enhancements...

Continue Reading
CHRD Stock Hits 52-Week Low: Analyzing Recent Developments

Updated Category News Views 169

CHRD Stock Analysis: 52-Week Low Insights In a fluctuating market, the stock of Chord Energy Corp (NASDAQ: CHRD) has recently touched a significant milestone, reaching a 52-week low at $126.96. This movement underscores ongoing volatility and varying investor sentiments within the energy sector. Notably, the stock experienced a substantial drop of 24.74% over the past...

Continue Reading
BitGo Faces Class Action Deadline: August 7, 2026

Updated Category News Views 9

Securities Class Action: A Wake-Up Call for BitGo Investors If you're holding onto those BitGo stocks, this might just be the wake-up call you didn't expect yet. New York's Faruqi & Faruqi, LLP is sounding the alarm bells, urging investors to mark August 7th, 2026 on their calendars. It's the deadline to file as a lead plaintiff in the securities class action against...

Continue Reading